Lumbar Disc Protrusion
Conditions
Interventions
Group 1 :Nothing
Group 2:Thoracolumbar Interfascial Plane Block and Compound Betamethasone Injection
Group 3:Thoracolumbar Interfascial Plane Block and Ropivacaine
Sponsors
The First Affiliated of AnHui Medical University
Eligibility
Sex/Gender
Male
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. Select patients undergoing percutaneous endoscopic lumbar discectomy at the selected stage, aged 18-80 years, with no gender restrictions; 2. American Society of Anesthesiologists (ASA) Grades I and II; 3. Body mass index (BMI) 18- 24 kg/m2.
Exclusion criteria
Exclusion criteria: 1. Serious respiratory and circulatory diseases: such as severe coronary heart disease, COPD, etc.; 2. Diseases of the endocrine system: pituitary tumor, severe diabetes, hypercortisol signs, pheochromocytoma, etc.; 3. Sinus bradycardia or AV block; 4. History of allergy to anesthetics; 5. Infection at the site of the puncture; 6. Mental illness such as schizophrenia, depression, history of chronic analgesic drugs, history of alcoholism, opioid dependence or inability to understand visual analogue scale (VAS); 7. History of bleeding disorders or abnormal coagulation function; 8. Anxious or depressed patients; 9. Pregnant women or maternity; 10. Patients with recurrence of lumbar disc herniation; 11. Situations where other investigators find inappropriate for this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Visual Analogue Scale (VAS) score;The 15-Item Quality of Recovery score scale;The Oswestry Disability Index; | — |
Secondary
| Measure | Time frame |
|---|---|
| Perioperative hemodynamics;Operation time;Postoperative hospital stay; | — |
Countries
China
Contacts
Public ContactWang Likui
Graduate School of AnHui Medical University
Outcome results
None listed